PROVISTA DIAGNOSTICS INC.

Profile

Company Names

PROVISTA DIAGNOSTICS INC.

Addresses

17301 N. PERIMETER DRIVE, SUITE 100, SCOTTSDALE, AZ 85085

17301 N. PERIMETER DR., SUITE 100, SCOTTSDALE, AZ 85255

6225 NORTH 24TH STREET, SUITE 150, PHOENIX, AZ 85016

Phone Numbers

602-224-5500
(602) 254-5500
(602) 952-3321

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2012

State Incorporated:

DELAWARE

Total Amount Raised:

$41,605,785.00

Number of Funding Rounds:

9
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
9
2018-05-17 
$2,205,633.00 
$5,000,000.00 
$2,794,367.00 
Equity, Debt 
8
2017-07-26 
$2,331,084.00 
$4,000,000.00 
$1,668,916.00 
Equity, Debt 
7
2016-10-13 
$2,564,948.00 
$6,000,000.00 
$3,435,052.00 
Equity, Debt 
6
2016-03-08 
$5,100,990.00 
$5,100,990.00 
$0.00 
Equity 
5
2015-07-23 
$6,046,254.00 
$6,046,254.00 
$0.00 
Equity 
4
2015-02-17 
$3,870,986.00 
$3,870,986.00 
$0.00 
Equity 
3
2014-04-08 
$6,000,000.00 
$6,000,000.00 
$0.00 
Equity 
2
2013-04-10 
$5,999,999.00 
$6,000,000.00 
$1.00 
Equity 
1
2012-02-17 
$7,485,891.00 
$7,485,891.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GARY 
 
ALTMAN 
EXECUTIVE OFFICER, DIRECTOR
CYNTHIA 
 
COLLINS 
DIRECTOR
JOHN 
 
FERMANIS 
EXECUTIVE OFFICER
WILLIAM 
 
GARTNER 
EXECUTIVE OFFICER
JEFFREY 
 
GILMAN 
DIRECTOR
JEFFREY 
R. 
GILMAN 
DIRECTOR
ROBERT 
J. 
HARIRI 
DIRECTOR
URIEL 
 
KUSIATIN 
EXECUTIVE OFFICER
URIEL 
E. 
KUSIATIN 
EXECUTIVE OFFICER
JOHN 
 
MACASKILL 
DIRECTOR
THOMAS 
 
MENDELL 
DIRECTOR
RAO 
 
MULPURI 
EXECUTIVE OFFICER
YOJI 
 
NIMURA 
DIRECTOR
DAVID 
 
REESE 
EXECUTIVE OFFICER, DIRECTOR
JOHN 
 
ZICARELLI 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2018-05-17 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2017-07-26 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2016-10-13 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-03-08 
D
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2015-07-23 
D
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2015-02-17 
D
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2014-04-08 
D
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2013-04-10 
D/A
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2012-02-17 
D
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2012-02-17 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#